Who is this drug for? 8 Bamlanivimab is a treatment option for people with COVID-19 who: • Are age 12 or older • Weigh 88 pounds or more • Have had mild to moderate symptoms for 10 days or less • Are at high risk to get very sick from COVID-19 This drug is not for people who are already in the hospital because of their COVID-19 symptoms. Am I at high risk? For adults, bamlanivimab may be an option if you: • Are age 65 or older • Have obesity, with a body mass index (BMI) of 35 or higher • Have diabetes, chronic kidney disease, or a condition that weakens the immune system • Take medication that weakens the immune system • Are age 55 or older and have heart disease, high blood pressure, or a long-term lung disease For pediatric patients age 12-17, bamlanivimab may be an option if you: 9 • Have obesity, with a BMI higher than 85 percent of patients your same age or gender • Have heart disease, sickle cell disease, or a long-term lung disease • Have a developmental condition, like cerebral palsy • Regularly use medical technology, like a ventilator or feeding tube If you’re not sure whether bamlanivimab is right for you, talk with your doctor. For more detailed information about risk, see the Fact Sheet for Healthcare Providers. 8 U.S. Food and Drug Administration: http://pi.lilly.com/eua/bamlanivimab-eua-fda-authorization-letter.pdf 9 U.S. Centers for Disease Control and Prevention: https://www.cdc.gov/healthyweight/bmi/calculator.html Page 4 | PP-BM-US-0012 November 2020 ©Lilly USA, LLC 2020. All rights reserved.